The Medyzen blog
Clinical Drug Insights
A clinical overview of semaglutide in India — mechanism, approved indications, real side-effect data, drug interactions, and what it costs after patent expiry.
Clinical Drug Insights
The documented semaglutide weight loss drug interactions: insulin and sulfonylurea hypoglycaemia risk, oral contraceptive and levothyroxine absorption, warfarin.
Clinical Drug Insights
A clinical reference on semaglutide cost in India: mechanism, real side-effect data, generic pricing after patent expiry, and hospital pharmacy stocking.
Clinical Drug Insights
Semaglutide availability in India after CDSCO approval and patent expiry: mechanism, approved indications, generic pricing, and drug interactions for prescribers.
Compliance
What Schedule H, H1 and X actually mean for a pharmacy: labelling, register-keeping, retention periods, and named examples of each drug category.
Compliance
Retail and wholesale drug licences compared on forms, buyers, floor area and staff qualification, with which one your pharmacy actually needs.
Revenue
What prescription leakage actually costs Indian hospitals, why it happens even with a pharmacy on-site, and the fixes that measurably reduce it.
Clinical Drug Insights
How pregnancy medicine safety is classified in India, what CDSCO warnings cover, and where evidence for common pregnancy prescriptions actually stands.
Clinical Drug Insights
The real, sourced side-effect and interaction profile of the antibiotics used for pneumonia in India, for prescribing clinicians and hospital pharmacies.
Clinical Drug Insights
The antibiotic classes ICMR guidelines recommend for community-acquired pneumonia in India, real resistance data, NPPA pricing, and stocking implications.
Clinical Drug Insights
Why pneumonia antibiotics go out of stock in Indian hospital pharmacies, which agents are hardest to keep on the shelf, and what ICMR and NLEM data show.
Clinical Drug Insights
Pneumonia guidelines in India explained for prescribers: empirical antibiotic choice, ICMR resistance data, and what it means for hospital pharmacy stocking.
Clinical Drug Insights
How Indian treatment guidelines classify community-acquired pneumonia antibiotics, resistance data, and what hospitals need to keep in stock.
Clinical Drug Insights
QT prolongation, CYP450 and anticoagulant interactions with macrolides and fluoroquinolones used for pneumonia, sourced from ICMR and peer-reviewed data.
Clinical Drug Insights
What community-acquired pneumonia antibiotics actually cost in India under NPPA ceiling pricing, ICMR treatment guidance, and what stocking gaps cost a hospital.
Operations
How FEFO rotation, reorder points and batch tracking cut expiry losses and dead stock in a hospital pharmacy, with what to check before writing anything off.
Costs & Economics
The sections a pharmacy business plan actually needs in India: budget breakdown, location strategy, growth plan, and financial projections, with real numbers.
Clinical Drug Insights
Why pediatric dose india calculation relies on weight-based and BSA methods, how common off-label paediatric prescribing is, and what CDSCO rules require.
Clinical Drug Insights
The drug classes and molecules used to treat PCOS in India — letrozole, clomiphene, metformin, combined oral contraceptives — and where guidelines place each.
Clinical Drug Insights
How Indian health insurance treats PCOS/PCOD under IRDAI's pre-existing disease and waiting-period rules, and what's actually reimbursable.
Clinical Drug Insights
PCOS treatment classes used in India, prevalence data, generic availability, and what reliable hospital pharmacy stocking of PCOS therapy requires.
Clinical Drug Insights
PCOS India diagnostic criteria, first-line drug classes, metformin versus combined pill evidence, and what a hospital pharmacy actually needs to stock.
Clinical Drug Insights
Interactions between metformin, spironolactone and combined oral contraceptives in PCOS treatment, sourced from randomised trials and meta-analyses.
Clinical Drug Insights
PCOS treatment cost in India explained by component: diagnostic workup, first-line medical management, fertility treatment, and what drives the total bill.
